Efficacy in drug-resistant epilepsy
Adjusting medications
Safety studies
Read More
Latest News
Ocrelizumab use throughout the MS clinical course: highlights from ECTRIMS 2025
October 15, 2025Early use and long-term safety of ofatumumab: highlights from ECTRIMS 2025
October 7, 2025ECTRIMS 2025 HIGHLIGHTS – SATURDAY, SEPTEMBER 27, 2025
September 27, 2025The 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis – 24-26 September 2025
The following summarizes some of the highlights from Day 3 of ECTRIMS 2025.